The Supreme Court tossed out ObamaCare lawsuit, California et al v. Texas, stating the plaintiffs have no standing.
Biden Budget Offers Potential Oversight Tool on 340B Program
The Biden administration’s budget includes new enforcement tools for oversight of the 340B program but the details will matter.
Easing Occupational Licensing Restrictions will help Americans Overcome Barriers to Employment
Removing occupational licensing barriers at the federal level provides more freedom to states to reduce requirements
Canadian Drug Importation Continues to Face Obstacles
HHS asks court to dismiss PhRMA lawsuit on Canadian drug importation, stating they have no standing.
Lack of Trust in Public Health Authorities Will Impact Debate on Medicare for All
The U.S. public health system has a trust problem due to their handling of COVID-19.
Sen. Rand Paul Grills Dr. Fauci on NIH Grants and Wuhan Institute of Virology
Increased oversight in how federal funding is spent for health research was made very clear in a May 11 Senate HELP hearing.
Biden Trips Badly on Intellectual Property in TRIPS
Days after praising World Intellectual Property Day, President Biden agrees to waive US COVID-19 patents.
Beware the Words Investment and Free
When government officials talk about “investment” and “free” programs, taxpayers need to hang onto their wallets.
All Nations Must Respect and Protect Intellectual Property Rights
World Intellectual Property (IP) Day is a good time to remind all countries of the need to protect and respect IP rights.
Pelosi’s Healthcare Nightmare Is Coming Back
Speaker Pelosi’s (D-Calif.) 2019 drug pricing bill was introduced again, with all the horribles it had before but more dangerous.